Analysis of factors associated with relapse in patients on their second course of isotretinoin for acne vulgaris

J Am Acad Dermatol. 2021 Mar;84(3):856-859. doi: 10.1016/j.jaad.2020.10.030. Epub 2020 Oct 21.

Authors

Patrick T Tran¹, Hannah S Berman¹, Erica Leavitt², Marcia Hogeling², Carol E Cheng³

Affiliations

¹ David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
² Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
³ Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. Electronic address: [email protected].

PMID: 33096132
DOI: 10.1016/j.jaad.2020.10.030

No abstract available

Publication types

Letter

MeSH terms

Acne Vulgaris / drug therapy*
Administration, Oral
Adolescent
Adult
Dermatologic Agents / administration & dosage*
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Isotretinoin / administration & dosage*
Male
Recurrence
Time Factors
Treatment Outcome
Young Adult

Substances

Dermatologic Agents
Isotretinoin